undamentalytics Newsletter
Sign in

Bio Green Med Solution, Inc. income statement

In fiscal 2025, Bio Green Med Solution, Inc. reported revenue of $747,000, up 1637.2% on the year before, operating income of −$8.4m (a -1128.1% margin) and net income of −$3.0m, or −$6.45 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue10101221000000012
Research and development10697111812944515201971—
Selling, general and administrative997986665567775——
General and administrative———————————————83
Operating income−18−15−16−15−18−22−16−14−9−10−11−22−28−25−12−8−3
Interest expense00———————————————
Net interest income——————————————000
Income before tax−21−16−15−15−12−23−16−14−8−9−10−22−26−26−12−3−2
Income tax−1−1−1−1−2−3−2−2−1−1−1−4−5−3−100
Net income−20−16−15−13−10−19−14−12−7−7−8−18−21−23−11−3−2
Diluted EPS−$379.01−$209.67−$127.87−$0.40−$0.31−$0.21−$25.73−$0.84−$9.36−$0.15−$0.82−$0.50−$6.54−$6419.18−$502.46−$6.45—
Diluted shares (average)————————2m3m15m37m47m4m—2m—
EBITDA−18−15−16−15−18−22−16−1423−10−11−22−28−25−12−8−3

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BGMS vs CTNTBGMS vs INEOBGMS vs YDDL

More: Distributors stocks compared, Consumer Discretionary sector, rankings of US companies

Figures from Bio Green Med Solution, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bio Green Med Solution, Inc.